Professional Documents
Culture Documents
21
464.74
5,169.55
e) Other expenditure
196.24
589.28
Exceptional Items
Minority Interest
11
12
13
14
15
18
17
16
Tax Expense
10
(111.25)
(0.57)
3.46
11,906.34
1,945.51
1.60
1.76
12,017.59
1,945.51
311.95
311.95
(111.25)
-
(84.10)
227.85
(137.72)
132.30
(84.61)
360.14
(248.97)
114.69
922.86
(333.58)
474.84
48.04
283.04
805.92
319.60
805.92
1,105.13
312.22
1,105.13
5A
Total Expenses
343.24
314.72
273.07
306.10
(467.94)
177.59
4245.62
5,512.13
6,274.69
3906.41
69.89
106.65
5442.24
(Unaudited)
(Unaudited)
6168.03
30/06/2015
Quarter Ended
3.17
3.28
10,442.53
1,852.91
587.31
587.31
19.64
606.95
160.66
767.61
767.61
77.01
300.82
1,145.45
1,145.45
4,714.46
248.16
385.45
252.56
(571.29)
4,399.58
1.03
5.22
10,643.23
1,852.91
200.70
200.70
(221.83)
(21.12)
47.69
26.57
1037.55
1,064.12
244.28
602.65
1,911.05
1,911.05
9,875.76
807.98
626.93
579.17
(290.35)
8152.03
11,786.82
176.55
5,859.90
11610.27
-48.77
(Unaudited)
Year Ended
1,199.81
1,510.00
759.17
508.38
30/09/2015
4.47
4.59
10,442.53
1,852.91
828.75
828.75
21.11
7.91
13.55
11,705.64
1,945.51
1,478.43
1,478.43
(639.62)
838.81
410.98
849.86
231.66
922.86
(0.51)
3.51
11,764.79
1,945.51
(99.59)
(3.31)
(102.90)
(137.72)
(240.62)
(84.15)
(324.77)
1,693.83
1,249.79
1,081.52
196.24
598.09
115.31
77.01
340.34
1,134.67
1,134.67
6,105.11
755.46
336.43
363.30
(805.82)
5,455.75
7,239.79
116.50
7,123.29
(Unaudited)
2,943.62
1,210.09
537.15
1,081.52
4,269.02
4,269.02
1,695.68
1,695.68
21,076.80
1,143.93
494.42
9,151.55
241.20
16981.87
25,345.82
225.13
25120.68
(Audited)
31/03/2015
(363.80)
7,753.37
10,847.23
47.01
10,800.22
(Unaudited)
30/09/2014
5,908.67
(Unaudited)
30/09/2014
1.38
1.54
11,856.74
1,945.51
268.61
0.32
268.93
(84.10)
184.83
132.70
317.53
114.69
432.22
48.04
296.49
776.75
776.75
4,983.02
400.76
329.44
324.43
(970.75)
4,899.14
5,759.77
37.18
5,722.58
(Unaudited)
30/06/2015
Quarter Ended
3.31
3.42
10,289.86
1,852.91
613.46
0.24
613.71
19.64
633.35
161.90
795.25
795.25
335.29
1,130.54
1,130.54
5,436.51
415.46
391.74
309.73
(658.71)
4,978.29
6,567.05
-68.19
6,635.24
(Unaudited)
30/09/2014
0.87
5.05
11,764.79
1,945.51
613.46
(2.99)
166.03
(221.83)
(55.80)
48.55
(7.25)
1,037.55
1,030.31
196.24
636.83
1,863.38
1,863.38
11,136.18
1,204.26
665.87
687.72
(1776.57)
10,354.89
12,999.55
153.68
12,845.87
(Unaudited)
30/09/2015
4.40
4.28
10,289.86
1,852.91
793.87
0.41
794.28
21.11
815.39
233.06
1,048.45
1,048.45
601.06
1,649.51
1,649.51
10,106.47
742.34
771.47
592.19
(616.61)
8,617.08
11,755.98
27.88
11,728.10
(Unaudited)
30/09/2014
CONSOLIDATED
Rs. In Lacs ( Except for per share data )
STANDALONE
Rs. In Lacs ( Except for per share data )
Unaudited Financial Results for the quarter ended 30th Sept, 2015
Expenses
Regd. Office : 7th Floor, Elite Square, 274, Perin Nariman Street,Fort,Mumbai- 400001.
Website: www.astecls.com, Tel no.022-61205600, Fax- 022-22618289, Email id: info@astecls.com
30/09/2015
Sr. No
PART I
Year Ended
7.91
6.73
11,588.13
1,945.51
1,477.54
0.72
1,478.26
(639.62)
838.64
419.35
1,257.99
1,693.83
2,951.82
115.31
1,284.00
4,351.12
4,351.12
22,430.46
1,661.99
1,268.73
1,244.00
72.40
18,183.33
26,781.58
129.47
26,652.11
(Audited)
31/03/2015
5
2
25.29%
45.97%
45.74%
83.15%
30.00%
4,920,399
9.32%
54.26%
8,943,925
5,836,581
16.85%
8,698,075
44.71%
1,813,055
8,698,075
44.71%
INVESTOR COMPLAINTS
- No of shares
- Percentage of shareholding
Promoters and promoter group shareholding
a) Pledged / Encumbered
- No of shares
- Percentage of shares (as a % of the total
shareholding of promoters and promoter group
Public shareholding
PARTICULARS OF SHAREHOLDING
49.00%
84.00%
9,061,980
9.15%
15.76%
1,695,000
7,772,150
41.95%
45.97%
83.15%
8,943,925
9.32%
16.85%
1,813,055
8,698,075
44.71%
49.00%
84.00%
9,061,980
9.15%
15.76%
1,695,000
7,772,150
41.95%
36.38%
65.97%
7,096,828
18.81%
34.03%
3,660,152
8,698,075
44.71%
(Un Audited)
5,442.24
69.89
474.84
227.85
1.76
1.60
(Un Audited)
6,168.03
106.65
589.28
(248.97)
3.46
(0.57)
Sd/(Ashok V Hiremath)
Managing Director
Friday, 06 th November, 2015
30/06/2015
Quarter Ended
30/09/2015
Particulars
3.17
3.28
606.95
767.61
(48.77)
5,908.67
(Audited)
31/03/2015
30/09/2014
1.03
5.22
(21.12)
1,064.12
176.55
11,610.27
4.47
4.59
849.86
1,081.52
47.01
10,800.22
30/09/2015
7.91
13.55
838.81
2,943.62
225.13
25,120.68
(Audited)
31/03/2015
Year ended
3 Above Financials include financial results of Behram Chemicals Pvt. Ltd. (65.63% subsidiary), Astec CropCare Pvt Ltd (100% Subsidiary of Astec) and
Astec Europe Sprl (50.10% subsidiary). The Financial Results of Comercializadora Agricola Agroastrachem Cia Ltda at Columbia (100% Subsidiary of
Astec) are not included as the company has not commercialised its operation.
4 Financials of Astec Europe Sprl for the period ended 30th September 2015 has not been consolidated in the financial statements, as the required
information was not avaialable. Further, we confirm that there is no material impact on the financials. However, audited financials till 31st
December 2014 has been consolidated for the said entity.
5 The company has only one reportable segment i.e. Agrochemicals.
6 Figures of the previous year have been regrouped/rearranged, wherever necessary.
7 Promoters of Astec and Godrej Agrovet Ltd (GAVL) have entered into Share Purchase Agreement dated 28th August 15 for transfer of 45.29% equity
shares to GAVL.
8 Exceptional items of Rs.92,286,284 consists Provision for non receivable Government Dues of Rs.28,068,164, Capital Work in Progress written-off of
Rs.33,316,153 and Provision for Doubtful Debts of Rs.30,901,967.
Prior Period items consists income of MAT Credit Receivable of Rs.6,955,779, Export incentive of Rs.8,154,248 and payment of statutory liabilities of
9
Rs.1,337,828
2 The above financial results have been subject to limited review by Statutory Auditor.
Notes:
The above unaudited financials results were reviewed and recommended by the Audit Committee and approved by the Board of Directors at their
1
meeting held on 06.11.2015.
10
PART II
30.00%
4,920,399
45.74%
25.29%
8,943,925
83.15%
45.97%
54.26%
5,836,581
8,698,075
44.71%
9.32%
16.85%
1,813,055
8,698,075
44.71%
49.00%
84.00%
9,061,980
9.15%
15.76%
1,695,000
7,772,150
41.95%
45.97%
83.15%
8,943,925
9.32%
16.85%
1,813,055
8,698,075
44.71%
49.00%
84.00%
9,061,980
9.15%
15.76%
1,695,000
7,772,150
41.95%
36.38%
65.97%
7,096,828
18.81%
34.03%
3,660,152
8,698,075
44.71%
As at
3/31/2015
Consolidated
As at
As at
9/30/2015
3/31/2015
Shareholders' funds
Share Capital
Reserves and surplus
194,550,550
1,190,633,940
194,550,550
1,170,563,722
194,550,550
1,176,479,260
194,550,550
1,158,813,340
1,385,184,490
1,365,114,272
1,371,029,810
1,353,363,890
209,762
508,977
Minority Interest
Non-current liabilities
Long-term borrowings
Deferred tax liabilities (net)
Other long term liabilities
Long-term Provisions
268,542,312
56,973,177
281,402,304
7,131,979
126,240,043
55,945,207
291,018,513
7,407,997
274,274,806
53,124,332
289,605,714
7,131,979
132,204,986
52,096,362
297,681,922
7,407,997
614,049,772
480,611,760
624,136,831
489,391,267
742,965,547
772,369,627
130,104,805
23,465,647
725,720,571
830,116,530
120,788,416
45,213,769
790,987,033
905,990,503
145,345,312
41,280,139
773,845,698
838,335,068
128,398,125
47,174,764
1,668,905,626
3,668,139,889
1,721,839,286
3,567,565,318
1,883,602,986
3,878,979,390
1,787,753,654
3,631,017,788
1,220,371,802
314,217
172,983,447
9,981,395
267,220,119
1,271,954,951
382,583
122,470,471
9,981,395
192,288,344
1,226,328,847
48,753,425
172,983,447
237,800
268,232,145
1,330,261,287
382,583
122,470,471
237,800
193,300,370
1,670,870,980
1,597,077,744
1,716,535,664
1,646,652,511
1,136,726
718,759,426
890,391,645
112,573,029
274,408,082
917,436
623,983,064
976,090,704
112,160,707
257,335,662
1,136,726
912,633,543
1,010,683,936
117,841,346
120,148,175
917,436
719,294,310
1,048,305,436
120,199,513
95,648,580
1,997,268,909
3,668,139,889
1,970,487,574
3,567,565,318
2,162,443,726
3,878,979,390
1,984,365,276
3,631,017,788
Current liabilities
Short-term borrowings
Trade payables
Other current liabilities
Short-term provisions
Total
Assets
Non-current assets
Fixed assets
Tangible Assets
Intangible Assets
Capital work-in-progress
Non-current investments
Long-term loans and advances
Current assets
Current investments
Inventories
Trade receivables
Cash and cash equivalents
Short-term loans and advances
Total
For Astec LifeSciences Limited
Sd/(Ashok V Hiremath)
Managing Director
Friday, 06 th November, 2015